Paper17689290
Interleukin-10 and the pathogenesis of human visceral leishmaniasis.
Nylén S and 1 other. Trends Immunol, 2007. Cited by 296 papers, by iCite.
Cite this record
ConductScience Library. Interleukin-10 and the pathogenesis of human visceral leishmaniasis. Papers, record 17689290. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/17689290
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics6
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Interleukin-10 | Major topic |
| Leishmaniasis, Visceral | Major topic |
| Animals | |
| Humans | |
| Leishmania donovani | |
| Leishmania infantum |
Source PubMed
Grants2
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by | Source |
|---|---|---|---|---|---|
| Z01AI000494 | NIH | NIH RePORTER | |||
| ZIAAI000494 | NIH | NIH RePORTER |
Cited by210
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 296 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42953821 | CD4+ and CD8+ lymphocyte responses and cytokine profiles in visceral leishmaniasis patients following effective treatment in distinct transmission settings in Bihar, India. | Front Immunol | 2026 | https://conductscience.org/library/papers/42953821 | PubMed |
| 42746096 | Natural product-based therapeutic strategies against Leishmania: mechanistic insights and emerging host-directed approaches. | Front Microbiol | 2026 | https://conductscience.org/library/papers/42746096 | PubMed |
| 42458246 | CoReGRN: a context-aware post-processing framework for gene regulatory network inference revealing regulatory signatures in HIV-Leishmaniasis. | BMC Genomics | 2026 | https://conductscience.org/library/papers/42458246 | PubMed |
| 42410916 | Gardiquimod Nanoemulsion Targets Cutaneous Leishmaniasis Lesions Reducing Systemic Toxicity and Parasite Burden. | Adv Healthc Mater | 2026 | https://conductscience.org/library/papers/42410916 | PubMed |
| 42353142 | Comparative RNA-Seq Analysis Reveals Macrophage Polarization and T Cell Exhaustion Signatures in Visceral Leishmaniasis. | Int J Mol Sci | 2026 | https://conductscience.org/library/papers/42353142 | PubMed |
| 41266459 | Leishmaniasis. | Nat Rev Dis Primers | 2025 | https://conductscience.org/library/papers/41266459 | PubMed |
| 40929455 | Concomitant use of anti-leishmanial therapy and antibacterial prophylaxis reduces plasma LPS levels and improves several aspects of experimental Leishmania infantum infection in golden hamsters. | Mem Inst Oswaldo Cruz | 2025 | https://conductscience.org/library/papers/40929455 | PubMed |
| 40741972 | Tick-borne coinfections modulate CD8+ T cell response and progressive leishmaniosis. | Infect Immun | 2025 | https://conductscience.org/library/papers/40741972 | PubMed |
| 40732663 | Immune-Pathological Correlates of Disease Severity in New-World Kala-Azar: The Role of Parasite Load and Cytokine Profiles. | Pathogens | 2025 | https://conductscience.org/library/papers/40732663 | PubMed |
| 40699063 | High resolution capillary western blot analysis of antibody reactivity in human visceral leishmaniasis. | Rev Inst Med Trop Sao Paulo | 2025 | https://conductscience.org/library/papers/40699063 | PubMed |
| 40287829 | An overview of host immune responses against Leishmania spp. infections. | Hum Mol Genet | 2025 | https://conductscience.org/library/papers/40287829 | PubMed |
| 39809978 | Regulatory B cells in parasitic infections: roles and therapeutic potential. | Parasitol Res | 2025 | https://conductscience.org/library/papers/39809978 | PubMed |
| 39781380 | The development and maintenance of immunity against visceral leishmaniasis. | Front Immunol | 2024 | https://conductscience.org/library/papers/39781380 | PubMed |
| 39564149 | T-cell and Soluble Co-inhibitory Receptor Expression in Patients With Visceral Leishmaniasis Are Markers of Treatment Response and Clinical Outcome. | Open Forum Infect Dis | 2024 | https://conductscience.org/library/papers/39564149 | PubMed |
| 39527629 | Malnutrition disrupts adaptive immunity during visceral leishmaniasis by enhancing IL-10 production. | PLoS Pathog | 2024 | https://conductscience.org/library/papers/39527629 | PubMed |
| 39311405 | Cytokine profiles, blood parasite load and clinical features of visceral leishmaniasis in West Pokot County, Kenya. | Parasitology | 2024 | https://conductscience.org/library/papers/39311405 | PubMed |
| 39159266 | Altered co-stimulatory and inhibitory receptors on monocyte subsets in patients with visceral leishmaniasis. | PLoS Negl Trop Dis | 2024 | https://conductscience.org/library/papers/39159266 | PubMed |
| 39090352 | Efficiency of Cysticidal Therapy Impacted by the Host's Immune Response in Neurocysticercosis Patients. | Mol Neurobiol | 2025 | https://conductscience.org/library/papers/39090352 | PubMed |
| 38881737 | The role of CD4+ T cells in visceral leishmaniasis; new and emerging roles for NKG7 and TGFβ. | Front Cell Infect Microbiol | 2024 | https://conductscience.org/library/papers/38881737 | PubMed |
| 38720445 | Apolipoprotein E Is Upregulated in Blood and Circulating Monocytes of Indian Patients With Visceral Leishmaniasis. | Parasite Immunol | 2024 | https://conductscience.org/library/papers/38720445 | PubMed |
Genes2
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| IFNG | 3458 | PubTator's text mining | https://conductscience.org/library/genes/3458 | NCBI Gene |
| IL10 | 3586 | PubTator's text mining | https://conductscience.org/library/genes/3586 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- References
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/17689290
GET https://conductscience.org/api/papers/v1/17689290/cited_by?page=2